Sanofi Today

Our Science

We chase the miracles of science to improve people’s lives. But we can’t do it alone. We work closely with healthcare professionals, patient advocates, governments and industry so we can have the biggest impact.

Trending

November 29, 2023

Partner Spotlight: Kymera and Sanofi chase “undruggable” targets in immunology

Targeted protein degradation is an investigational new treatment approach that may have major implications in the immunology and inflammation space.

October 10, 2023

Tackling atopic dermatitis from all angles

Partner Spotlight: miRecule brings the power of RNA therapeutics to rare diseases

July 27, 2023

Partner Spotlight: miRecule and Sanofi drive the emergence of RNA therapeutics for Rare Diseases

In case you missed it

June 12, 2023

Sanofi x Viva Tech 2023: Artificial Intelligence, Real-Life Impact

May 16, 2023

Rethinking the science of COPD

May 17, 2023

Building a More Equitable Future through Inclusive Clinical Trials

Spotlight Messenger RNA

June 12, 2022

Sanofi x Viva Tech 2023: Artificial Intelligence, Real-Life Impact

November 1, 2021

mRNA technology platform

March 7, 2023

Adjusting to Life with Multiple Myeloma: Bernard’s Story

Everything About Our Science

Year

November 29, 2023

Partner Spotlight: Kymera and Sanofi chase “undruggable” targets in immunology

October 10, 2023

Tackling atopic dermatitis from all angles

July 27, 2023

Partner Spotlight: miRecule and Sanofi drive the emergence of RNA therapeutics for Rare Diseases

July 25, 2023

Harnessing the potential of mRNA to overcome major healthcare challenges

June 28, 2023

mRNA Technology: Vaccines and Beyond

June 22, 2023

Following the Science to Improve Care in Rare Blood Disorders

June 21, 2023

From Aspirations to Reality: My Journey as a Woman Scientist to Redefine Hemophilia Therapies

June 19, 2023

AI Goes Industrial

June 19, 2023

How digital technologies are accelerating our drug discovery and development process